encapsulated antigen vs surface displayed antigens
These are two methods of processing and presenting antigens to human body.
Nanocarriers need to be degraded for encapsulated antigens to trigger cellular immune response, while the surface displayed antigens primarily lead to humoral immune response.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical engineering
Biomedical Sciences
Related
encapsulated antigen vs surface displayed antigens
current studies identifying epitopes
encapsulated antigen vs surface displayed antigens
The effect of glycyrrhizic acid on the humoral immune response in mice
How green tea extract benefits the immune system
Protein-Based Vaccines in Clinical Trials for COVID-19
Nanomaterial-based Immune Modulation for SARS-CoV-2
encapsulated antigen vs surface displayed antigens
current studies identifying epitopes
Influence of SARS-CoV and MERS-CoV Knowledge on SARS-CoV-2 Vaccine Development